058820 — CMG Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for CMG Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	215	3,165	-388	6,455	2,695
Depreciation
Amortisation
Non-Cash Items	4,882	948	6,587	-340	1,681
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-4,589	-976	-3,546	-4,764	-7,432
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,944	5,629	4,938	3,909	290
Capital Expenditures	-9,650	-3,951	-10,308	-15,246	-31,747
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3,358	-4,529	-560	-12,975	-23,995
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-13,009	-8,480	-10,868	-28,221	-55,743
Financing Cash Flow Items	—	—	—	—	292
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities	-461	-484	5,628	21,095	56,783
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-10,526	-3,285	-303	-3,213	1,346